Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Drug repositioning can save time and money but needs more support.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Researchers found several compounds that could potentially treat Zika virus.

Early treatment with finasteride and minoxidil can effectively reverse hereditary hair loss.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

Warts in HIV-positive men can have serious abnormal cell growth, needing careful analysis and treatment to prevent cancer.

Using cidofovir cream for a rare skin disease can cause skin darkening.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New tests detect finasteride and dutasteride in urine quickly and easily.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Anti-androgens might help reduce COVID-19 severity in men.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

The market for these drugs is expected to grow.

Repurposing existing drugs can quickly and cheaply find new treatments for diseases.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.